Research programme - beta lactamase inhibitors - Wockhardt

Drug Profile

Research programme - beta lactamase inhibitors - Wockhardt

Alternative Names: WCK 4234

Latest Information Update: 28 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wockhardt
  • Class Antibacterials
  • Mechanism of Action Beta lactamase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Bacterial infections

Most Recent Events

  • 16 Jun 2016 Early research in Bacterial infections in India (unspecified route) before June 2016
  • 16 Jun 2016 Pharmacokinetics and antimicrobial activity data from an in vitro study in Bacterial infections released by Wockhardt
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top